Morgan Stanley upgraded Tandem Diabetes (TNDM) to Overweight from Equal Weight. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on TNDM: Tandem Diabetes price target raised to $60 from $58 at Barclays Tandem Diabetes price target lowered to $40 from $43 at UBS Tandem Diabetes price target lowered to $56 from $57 at Canaccord Tandem Diabetes price target lowered to $37 from $39 at Baird Tandem Diabetes Care Reports Strong Q3 Growth